Repifermin shows positive results in phase II trial as treatment of chronic venous ulcers May 26, 2000
Selective RXR agonists designed at Allergan particularly useful for skin-related diseases May 19, 2000
Ligand releases new data confirming Ontak's effectiveness in patients with severe psoriasis May 15, 2000
RSS